AkesoGenX

United States
Calexico, California, United States, 80021

Company profile

AkesoGenX company profile

AkesoGenX designs and develops nano-diagnostic and nano-therapeutic medical products for the treatment of cancer. The company's primary goal is to move the Kanzius RF field treatment forward to treat patients with highly lethal and resistant forms of cancer. AkesoGenX was incorporated in 2013 and is based in Westminster, Colorado.

Business identity

Phone number
303 579 3663
Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2013-01-01, Year

Headquarters

Postal code
80021
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$1.5M
Last funding
Series Unknown / $1.3M / 2014-01-17
Last equity funding
Series Unknown / $1.3M
Founders
2

Founders and investors

Founders

Robert ZavalaSteven Curley